Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ben Trzaskoma"'
Autor:
Tina Duong, Hannah Staunton, Jessica Braid, Aurelie Barriere, Ben Trzaskoma, Ling Gao, Tom Willgoss, Rosangel Cruz, Nicole Gusset, Ksenija Gorni, Sharan Randhawa, Lida Yang, Carole Vuillerot
Publikováno v:
Frontiers in Neurology, Vol 12 (2022)
The 32-item Motor Function Measure (MFM32) is an assessment of motor function used to evaluate fine and gross motor ability in patients with neuromuscular disorders, including spinal muscular atrophy (SMA). Reliability and validity of the MFM32 have
Externí odkaz:
https://doaj.org/article/bfda0d067a5e46119881b84dee5d1662
Autor:
Steven W. Pipe, Ben Trzaskoma, Miranda Minhas, Michaela Lehle, Richard H. Ko, Ling Gao, Johnny Mahlangu, Christine L. Kempton, Craig M. Kessler, Rebecca Kruse-Jarres
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. :100191
Autor:
Miguel, Escobar, Amy, Dunn, Doris, Quon, Ben, Trzaskoma, Lucy, Lee, Richard H, Ko, Shannon L, Carpenter
Publikováno v:
Haemophilia. 28
Autor:
Steven W. Pipe, Ben Trzaskoma, Miranda Minhas, Michaela Lehle, Richard H. Ko, Ling Gao, Johnny Mahlangu, Christine L. Kempton, Craig M. Kessler, Rebecca Kruse-Jarres
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 7:100077
Autor:
Doris Quon, Shannon L. Carpenter, Amy L. Dunn, Lucy Lee, Richard H. Ko, Miguel A. Escobar, Ben Trzaskoma
Publikováno v:
Blood. 136:30-31
Introduction: Emicizumab is a subcutaneously administered, bispecific, humanized monoclonal antibody that bridges factor (F)IXa and FX to restore the function of missing activated FVIII in persons with hemophilia A (PwHA). This study (NCT03361137) wa
Autor:
Steven D. Nathan, Ian Glaspole, David J. Lederer, Susan L. Limb, Ben Trzaskoma, Lisa Lancaster, Marilyn K. Glassberg, Athol U. Wells, Carlos A. Pereria, Ulrich Costabel
Publikováno v:
Diffuse Parenchymal Lung Disease.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 14(6)
Background Dornase alfa administered via jet nebulizer is indicated as a chronic respiratory medication for cystic fibrosis (CF) patients. Efficacy and safety of dornase alfa via an electronic nebulizer with vibrating membrane technology have not bee
Publikováno v:
Chest. 140:232A